Karyopharm Therapeutics(DE:25K0)
€0.020.00 (0.00%)
DE:25K0
Karyopharm Therapeutics earnings date
€0.02
At close:0.00 (0.00%)
Karyopharm Therapeutics (25K0) Q2 2022 Earnings Report
1 Followers
DE:25K0 Q2 2022 EPS Results
- Actual EPS
- -EUR 8.34
- Consensus EPS
- -EUR 8.52
- Beat/Miss
- Beat by +EUR 0.18
- One Year Ago EPS
- -EUR 9.55
DE:25K0 Q2 2022 Revenue Results
- Actual Revenue
- EUR 35.58M
- Expected Revenue
- EUR 32.25M
- Beat/Miss
- Beat by +EUR 3.33M
- YoY Revenue Growth
- +75.56%
Earnings Announcement Details
- Quarter
- Q2 2022
- Date
- 08/04/2022
- Time
- Before Open
- Conference Call
- Thursday, August 4, 2022
DE:25K0 Upcoming Earnings
Karyopharm Therapeutics's next earnings date is estimated for February 10, 2027, based on past reporting schedules.
Q2 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:25K0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 10, 2027 | 2026 (Q4) | ―- | -5.12 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.30- | -3.43 | ― | |
| Aug 13, 2026 | 2026 (Q2) | -1.23-2.08 | -3.87 | 46.30% (+1.79) | |
| May 14, 2026 | 2026 (Q1) | -1.27-1.11 | -2.48 | 55.23% (+1.37) | |
| Feb 12, 2026 | 2025 (Q4) | -1.79-5.12 | -3.23 | -58.61% (-1.89) | |
| Nov 03, 2025 | 2025 (Q3) | -3.11-3.43 | -3.5 | 2.05% (+0.07) | |
| Aug 11, 2025 | 2025 (Q2) | -3.66-3.87 | -2.69 | -44.00% (-1.18) | |
| May 12, 2025 | 2025 (Q1) | -3.96-2.48 | -4.3 | 42.29% (+1.82) | |
| Feb 19, 2025 | 2024 (Q4) | -3.52-3.23 | -4.84 | 33.33% (+1.61) | |
| Nov 05, 2024 | 2024 (Q3) | -3.54-3.50 | -4.04 | 13.33% (+0.54) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

